PERTURBED CELL-GROWTH AND ARA-C PHARMACOLOGY IN ACUTE MYELOID-LEUKEMIA (AML) AT DIAGNOSIS AND AT RELAPSE

被引：0
|
作者：
KARP, JE [1 ]
DONEHOWER, RC [1 ]
DOLE, GB [1 ]
BURKE, PJ [1 ]
机构：
[1] JOHNS HOPKINS UNIV HOSP,CTR ONCOL,BALTIMORE,MD 21205
来源：
CELL AND TISSUE KINETICS | 1987年 / 20卷 / 02期
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：244 / 244
页数：1
相关论文
共 50 条
  • [41] DIFFERENCES IN ARA-C METABOLISM, P-GLYCOPROTEIN AND CD34 EXPRESSION ARE ASSOCIATED WITH AUTONOMOUS GROWTH IN ADULT ACUTE MYELOID-LEUKEMIA
    BOEKHORST, PAWT
    SONNEVELD, P
    LOWENBERG, B
    BLOOD, 1993, 82 (10) : A256 - A256
  • [42] CYTOSINE-ARABINOSIDE (ARA-C) AS AN INVITRO INDUCER OF DIFFERENTIATION OF HUMAN MYELOID-LEUKEMIA CELLS
    PAPAC, RJ
    FRANCIS, L
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 305 - 305
  • [43] Influence of rhGM-CSF on Ara-C sensitivity of patients with acute myeloid leukemia in relapse: A flow cytometry study
    Lacombe, F
    Puntous, M
    Dumain, P
    ConyMakhoul, P
    Belloc, F
    Bernard, P
    Boisseau, M
    Reiffers, J
    LEUKEMIA RESEARCH, 1996, 20 (06) : 481 - 489
  • [44] Autophagy induction of Acute Myeloid Leukemia (AML) cells after treatment with low dose-cytarabine (Ara-C) and enhanced cytocidal effect on AML cells by combined treatment with ara-c plus lenograstim
    Tang, Yongmin
    Li, Lixia
    Wang, Di
    Shen, Hongqiang
    Qian, Baiqin
    Luo, Chunfang
    Zhang, Haizhong
    BLOOD, 2007, 110 (11) : 114B - 114B
  • [45] CHILDHOOD ACUTE MYELOGENOUS LEUKEMIA (AML) REFRACTORY TO ANTHRACYCLINE CYTARABINE (ARA-C) THERAPIES
    KALWINSKY, D
    LOOK, AT
    MIRRO, J
    DAHL, GV
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 193 - 193
  • [46] MECHANISMS OF GROWTH-FACTOR EXPRESSION IN ACUTE MYELOID-LEUKEMIA (AML)
    FIEDLER, W
    SUCIU, E
    WITTLIEF, C
    OSTERTAG, W
    HOSSFELD, DK
    LEUKEMIA, 1990, 4 (07) : 459 - 461
  • [47] Effect of Ara-C on T-Cell Function and Flotetuzumab Activity in Pediatric Acute Myeloid Leukemia
    Gopalakrishnapillai, Anilkumar
    Kisielewski, Anne
    Bonvini, Ezio
    Muth, John
    Davidson-Moncada, Jan K.
    Kolb, E. Anders
    Barwe, Sonali
    BLOOD, 2019, 134
  • [48] HIGH-DOSE ARA-C AND MITOXANTRONE (HAM) IN ACUTE MYELOID-LEUKEMIA (AML) FROM SALVAGE TO 1ST-LINE TREATMENT - DATA FROM AMLCG
    BUCHNER, T
    HIDDEMANN, W
    LOFFLER, H
    LUDWIG, WD
    MASCHMEYER, G
    AUL, C
    LENGFELDER, E
    HEINECKE, A
    BRITISH JOURNAL OF HAEMATOLOGY, 1992, 82 (01) : 280 - 280
  • [49] INHIBITION OF CHRONIC MYELOID-LEUKEMIA CELL-GROWTH BY CIRCULAR ANTISENSE OLIGONUCLEOTIDES
    ROWLEY, PT
    THOMAS, MA
    KOSCIOLEK, BA
    KOOL, ET
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 235 - 235
  • [50] INTENSIVE POSTREMISSION THERAPY WITH ARA-C IN ADULTS WITH ACUTE MYELOID-LEUKEMIA - INITIAL RESULTS OF A CALGB PHASE-III TRIAL
    MAYER, RJ
    DAVIS, RB
    SCHIFFER, CA
    BERG, DT
    SARNO, E
    FREI, E
    LEUKEMIA, 1992, 6 : 66 - 67
12345